Mogrify

@Mogrify_UK

Mogrify™ will develop proprietary tailored cellular conversions that power every future cell therapy.

Vrijeme pridruživanja: siječanj 2019.

Tweetovi

Blokirali ste korisnika/cu @Mogrify_UK

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Mogrify_UK

  1. prije 13 sati

    What skills are important to become a successful leader in ? Our CBO, Dr. Karin Schmitt, as a part of the blog, sat down with to discuss her career, current projects and the importance of authentic .

    Poništi
  2. prije 17 sati

    Our commercial team is growing, we are looking for highly-skilled and ambitious individuals who demonstrate commercial and scientific excellence to join our team. Roles include; , Apply at:

    Poništi
  3. 4. velj

    Thank you . We're honored to have been selected as a finalist in the Award for Business Innovation category in the 2020 Business Excellence Awards. Find out more about the awards here:

    Poništi
  4. 4. velj

    Researchers at have used imaging mass cytometry to simultaneously quantify 35 biomarkers, resulting in high-dimensional pathology images of tumor tissue from 352 patients with . Published in -

    Poništi
  5. 3. velj

    In last summers' issue of , Pierre-Louis Joffrin of , writes about and discusses if it's falling short of its potential? Now available as a

    Poništi
  6. 30. sij

    Next week Pierre-Louis Joffrin, CDE, will be attending the World Congress in . We're looking forward to connecting with disruptive innovators, investors and partners across the fields of and .

    Poništi
  7. 29. sij

    Have you read the latest edition of ? This week focuses on , with commentary (Pages 16-17) from on our roadmap for rapid growth and what you can expect to see in 2020. Read more at:

    Poništi
  8. 28. sij

    Today we are delighted to announce $1.1M in additional from allowing us to assess our cartilage therapy, before entering . Read more at:

    Poništi
  9. 27. sij

    During the recent BIO-Europe conference, our Chair, Dr. Jane Osbourn OBE met with from to give her view on the state of the industry and reflect on her roles at , Cambridge Antibody Technology and MedImmune.

    Poništi
  10. 24. sij

    Researchers at have discovered a new type of killer T-cell that offers hope of a “one-size-fits-all” . Published this week in describing a unique TCR that can recognize many types of cancer.

    Poništi
  11. 22. sij

    Deliver world-class science, commercial success, patient impact with a at Mogrify. Our CEO, joins and 's Careers in Discovery : Leaders in and R&D. Listen at:

    Poništi
  12. 21. sij

    What advice would you give to young researchers? Sitting Down with , Dr. Jane Osbourn OBE, our Chair, explains the importance of collaboration and finding your passion in the and industry. Read more at:

    Poništi
  13. 16. sij

    We’re looking forward to next month’s Annual Cell & Gene Therapy Summit in . Our CEO, Dr. Darrin Disley OBE will be discussing our platform and it's potential for transforming the development of

    Poništi
  14. 14. sij

    After becoming the first woman to win ’s Life Time Achievement Award, our Chair, Dr. Jane Osbourn OBE sat down with to discuss her career path and success in antibody . Read the full article at:

    Poništi
  15. 10. sij

    We are heading to the NK Cell Workshop at . Co-hosted by and , we're looking forward to an update on the progress in NK and how clinical applications have taken advantage of recent technological advances.

    Poništi
  16. 6. sij

    Do you want to push the boundaries of ? We are a Research Associate to join our team in . If you are a highly skilled and ambitious , please find more information and apply at:

    Poništi
  17. 3. sij

    We're looking forward to a busy week in , starting with the Cell & Gene Therapies State of the Industry Briefing . Get in touch if you're in the area & would like to meet with us

    Poništi
  18. 30. pro 2019.

    How could -mediated pave the way to human cell models and cost-effective ? Read the interview with our Corporate Development Executive, Pierre-Louis Joffrin to learn more:

    Poništi
  19. 27. pro 2019.

    In case you missed it: Read the piece 'A new technology for direct ' in by our Co-Founder & CSO, Prof. to find out more about our systematic approach to cell conversion:

    Poništi
  20. 26. pro 2019.

    Do you want to drive the revolution of ? We are an Alliance Manager to join our team in . If you are a highly skilled and ambitious , please find more information and apply at:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·